enVVeno Medical (NVNO) Competitors $4.27 +0.14 (+3.39%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$4.26 0.00 (-0.12%) As of 07/16/2025 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NVNO vs. CATX, SNWV, NNOX, XAIR, NYXH, DRTS, STIM, ZIMV, SMTI, and BWAYShould you be buying enVVeno Medical stock or one of its competitors? The main competitors of enVVeno Medical include Perspective Therapeutics (CATX), Sanuwave Health (SNWV), Nano-X Imaging (NNOX), Beyond Air (XAIR), Nyxoah (NYXH), Alpha Tau Medical (DRTS), Neuronetics (STIM), ZimVie (ZIMV), Sanara MedTech (SMTI), and Brainsway (BWAY). These companies are all part of the "medical equipment" industry. enVVeno Medical vs. Its Competitors Perspective Therapeutics Sanuwave Health Nano-X Imaging Beyond Air Nyxoah Alpha Tau Medical Neuronetics ZimVie Sanara MedTech Brainsway enVVeno Medical (NASDAQ:NVNO) and Perspective Therapeutics (NYSE:CATX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, valuation, analyst recommendations, media sentiment, profitability and earnings. Does the media prefer NVNO or CATX? In the previous week, Perspective Therapeutics had 4 more articles in the media than enVVeno Medical. MarketBeat recorded 5 mentions for Perspective Therapeutics and 1 mentions for enVVeno Medical. enVVeno Medical's average media sentiment score of 1.89 beat Perspective Therapeutics' score of 0.60 indicating that enVVeno Medical is being referred to more favorably in the media. Company Overall Sentiment enVVeno Medical Very Positive Perspective Therapeutics Positive Do insiders & institutionals believe in NVNO or CATX? 34.7% of enVVeno Medical shares are held by institutional investors. Comparatively, 54.7% of Perspective Therapeutics shares are held by institutional investors. 16.0% of enVVeno Medical shares are held by company insiders. Comparatively, 3.5% of Perspective Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has better earnings & valuation, NVNO or CATX? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioenVVeno MedicalN/AN/A-$21.82M-$1.18-3.62Perspective TherapeuticsN/AN/A-$46.51MN/AN/A Is NVNO or CATX more profitable? enVVeno Medical has a net margin of 0.00% compared to Perspective Therapeutics' net margin of -4,096.66%. Perspective Therapeutics' return on equity of -27.40% beat enVVeno Medical's return on equity.Company Net Margins Return on Equity Return on Assets enVVeno MedicalN/A -51.32% -48.23% Perspective Therapeutics -4,096.66%-27.40%-23.16% Which has more volatility and risk, NVNO or CATX? enVVeno Medical has a beta of 0.93, indicating that its share price is 7% less volatile than the S&P 500. Comparatively, Perspective Therapeutics has a beta of 1.18, indicating that its share price is 18% more volatile than the S&P 500. Do analysts prefer NVNO or CATX? Perspective Therapeutics has a consensus target price of $12.56, indicating a potential upside of 207.73%. Given Perspective Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Perspective Therapeutics is more favorable than enVVeno Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score enVVeno Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Perspective Therapeutics 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 3 Strong Buy rating(s) 3.18 SummaryPerspective Therapeutics beats enVVeno Medical on 9 of the 13 factors compared between the two stocks. Get enVVeno Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for NVNO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NVNO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NVNO vs. The Competition Export to ExcelMetricenVVeno MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$72.34M$6.58B$5.51B$9.31BDividend YieldN/A1.30%4.25%4.09%P/E Ratio-3.6225.4928.1219.69Price / SalesN/A67.67439.46100.25Price / CashN/A20.0535.5357.53Price / Book1.784.668.235.67Net Income-$21.82M$174.76M$3.23B$257.51M7 Day Performance-1.16%-1.59%-0.52%-0.16%1 Month Performance-0.47%3.25%6.71%9.89%1 Year Performance-28.24%3.69%27.10%15.08% enVVeno Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NVNOenVVeno Medical0.629 of 5 stars$4.27+3.4%N/A-29.5%$72.34MN/A-3.6230Positive NewsCATXPerspective Therapeutics2.3638 of 5 stars$3.90-2.5%$12.56+221.9%-67.6%$289.49MN/A0.0070SNWVSanuwave HealthN/A$33.27-8.0%N/AN/A$284.66M$36.19M-7.3040NNOXNano-X Imaging2.5165 of 5 stars$4.91-4.7%$9.50+93.5%-47.6%$283.70M$11.28M-5.46190News CoveragePositive NewsAnalyst UpgradeXAIRBeyond Air4.6113 of 5 stars$3.16+3.6%$1.50-52.5%-72.0%$272.93M$3.70M-4.0070Gap UpHigh Trading VolumeNYXHNyxoah2.5262 of 5 stars$7.93+1.1%$14.50+82.8%-15.2%$270.10M$4.36M-3.72110Positive NewsDRTSAlpha Tau Medical3.1278 of 5 stars$3.15-2.5%$8.00+154.0%+43.5%$267.18MN/A-6.8580Positive NewsSTIMNeuronetics1.7813 of 5 stars$3.74-3.1%$5.50+47.1%+80.0%$247.25M$74.89M-2.85180ZIMVZimVie2.3223 of 5 stars$8.84-1.0%$16.33+84.8%-54.4%$246.17M$443.55M-12.451,770SMTISanara MedTech2.1161 of 5 stars$27.23-5.7%$49.50+81.8%-12.4%$242.08M$86.67M-20.3260Positive NewsHigh Trading VolumeBWAYBrainsway2.6511 of 5 stars$12.20-0.2%$14.25+16.8%+81.9%$230.58M$41.02M61.00120Gap Up Related Companies and Tools Related Companies CATX Alternatives SNWV Alternatives NNOX Alternatives XAIR Alternatives NYXH Alternatives DRTS Alternatives STIM Alternatives ZIMV Alternatives SMTI Alternatives BWAY Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NVNO) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding enVVeno Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share enVVeno Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NVNO Stock Alerts